📑Antibioticos asociados - uso ocular c/vasocons, Antimicoticos topicos 1g/100 g polvo, Enalapril 5 mg, Risperidona 1 mg gotas, Tobramicina 0,3 g/100 ml
Procurement process summary
This process is to purchase Antibioticos asociados - uso ocular c/vasocons, Antimicoticos topicos 1g/100 g polvo, Enalapril 5 mg, Risperidona 1 mg gotas, Tobramicina 0,3 g/100 ml.
This contract was awarded by 🇺🇾 Dirección Nacional de Sanidad Policial for an amount of UYU 37,460 to 1 supplier. It was published on 2003-04-01 through not reported
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇺🇾 Dirección Nacional de Sanidad Policial Buying unitnot reported Publication date2003-04-01 Contest statusnot reported DescriptionR/210231300018Awards
This award was granted to ROEMMERS S.A.- by Dirección Nacional de Sanidad Policial for an amount of UYU 37,460. The procurement process was conducted through Not available for the category of Not available. The award was granted on 2003-02-03.
| Supplier | Amount | Award date |
|---|---|---|
| 🇺🇾 ROEMMERS S.A.- | UYU 37,460 | 2003-02-03 |
Market context and opportunities
The execution of this contract allows the entity Dirección Nacional de Sanidad Policial to fulfill its public service objectives efficiently.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberUY_ocds-yfs5dr-4561-R-210231300018Publication date2003-04-01Contract datenot reportedAward date2003-02-03Categoriesnot reportedPurchase modalitynot reportedMethod detailsnot reportedStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
